163 related articles for article (PubMed ID: 1399431)
41. Evaluation of morphological/immunohistochemical versus nuclear medicine imaging modalities in detecting metastatic bone and/or marrow deposits in neuroblastoma patients.
Zaher Ael-S; Zaher AM; Moneer MM; El Gamal BM
J Egypt Natl Canc Inst; 2011 Jun; 23(2):79-88. PubMed ID: 22099965
[TBL] [Abstract][Full Text] [Related]
42. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.
Geatti O; Shapiro B; Sisson JC; Hutchinson RJ; Mallette S; Eyre P; Beierwaltes WH
J Nucl Med; 1985 Jul; 26(7):736-42. PubMed ID: 4009283
[TBL] [Abstract][Full Text] [Related]
43. [Scintigraphic diagnosis of neuroblastoma using meta-iodobenzylguanidine].
Kimmig B; Brandeis WE; Eisenhut M; Ludwig R; Adolph J
Klin Padiatr; 1986; 198(3):224-9. PubMed ID: 3723986
[TBL] [Abstract][Full Text] [Related]
44. [Follow up control of stage IV neuroblastoma: 123I-MIBG scintigraphy, bone scintigraphy and catecholamine metabolites].
Kohnert K; Lerch H; Thelen M; Jürgens H; Schober O
Nuklearmedizin; 1996 Dec; 35(6):220-4. PubMed ID: 8999421
[TBL] [Abstract][Full Text] [Related]
45. Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma.
Perel Y; Conway J; Kletzel M; Goldman J; Weiss S; Feyler A; Cohn SL
J Pediatr Hematol Oncol; 1999; 21(1):13-8. PubMed ID: 10029806
[TBL] [Abstract][Full Text] [Related]
46. Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience.
Jacobs A; Delree M; Desprechins B; Otten J; Ferster A; Jonckheer MH; Mertens J; Ham HR; Piepsz A
Pediatr Radiol; 1990; 20(3):157-9. PubMed ID: 2352793
[TBL] [Abstract][Full Text] [Related]
47. 131I-MIBG scintigraphy in neural crest tumours.
Samuel AM; Murugesan S; Kurkure PA; Advani SH; Sonawane GA; Noronha OP
Indian J Cancer; 1994 Jun; 31(2):103-10. PubMed ID: 7927441
[TBL] [Abstract][Full Text] [Related]
48. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
Sone T; Fukunaga M; Otsuka N; Morita R; Muranaka A; Yanagimoto S; Tomomitsu T; Nakayama H; Harada T
J Nucl Med; 1985 Jun; 26(6):604-8. PubMed ID: 3158726
[TBL] [Abstract][Full Text] [Related]
49. Undeserved bad press for bone scans: reply.
Osmanagaoglu K
Eur J Nucl Med; 1994 Oct; 21(10):1167-8. PubMed ID: 7828628
[No Abstract] [Full Text] [Related]
50. Meta-iodobenzylguanidine scintigraphy in neuroblastoma--a comparison with conventional X-ray and ultrasound.
Müller-Gärtner HW; Erttmann R; Helmke K
Pediatr Hematol Oncol; 1986; 3(2):97-109. PubMed ID: 3153232
[TBL] [Abstract][Full Text] [Related]
51. Specificity of radioiodinated MIBG for neural crest tumors in childhood.
Leung A; Shapiro B; Hattner R; Kim E; de Kraker J; Ghazzar N; Hartmann O; Hoefnagel CA; Jamadar DA; Kloos R; Lizotte P; Lumbroso J; Rufini V; Shulkin BL; Sisson JC; Thein A; Troncone L
J Nucl Med; 1997 Sep; 38(9):1352-7. PubMed ID: 9293786
[TBL] [Abstract][Full Text] [Related]
52. [Indications for MIBG scintigraphy in the diagnosis of neuroblastoma].
Hausegger KA; Fueger GF; Ebner F; Urban C
Nuklearmedizin; 1989 Feb; 28(1):34-40. PubMed ID: 2710644
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis and treatment of neuroblastoma using metaiodobenzylguanidine.
Edeling CJ; Frederiksen PB; Kamper J; Jeppesen P
Clin Nucl Med; 1987 Aug; 12(8):632-7. PubMed ID: 3665302
[TBL] [Abstract][Full Text] [Related]
54. [Bone marrow metastases of neuroblastoma: MRT in comparison with bone marrow cytology and mIBG scintigraphy].
Benz-Bohm G; Gross-Fengels W; Widemann B; Linden A
Rofo; 1990 May; 152(5):523-7. PubMed ID: 2160683
[TBL] [Abstract][Full Text] [Related]
55. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.
Voûte PA; Hoefnagel CA; de Kraker J; Valdes Olmos R; Bakker DJ; van de Kleij AJ
Prog Clin Biol Res; 1991; 366():439-45. PubMed ID: 2068157
[No Abstract] [Full Text] [Related]
56. [Scintigraphic localization of metastatic neuroblastoma using 131I-MIBG].
Hoshi K; Midorikawa S; Mizukoshi H; Togawa T; Kikuta A
Rinsho Hoshasen; 1986 Jan; 31(1):131-4. PubMed ID: 3702103
[No Abstract] [Full Text] [Related]
57. Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response.
Reuland P; Geiger L; Thelen MH; Handgretinger R; Haase B; Müller-Schauenburg W; Niethammer D; Bares R
J Pediatr Hematol Oncol; 2001 Oct; 23(7):437-42. PubMed ID: 11878578
[TBL] [Abstract][Full Text] [Related]
58. Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumor localization of 99mTc-MDP.
Podrasky AE; Stark DD; Hattner RS; Gooding CA; Moss AA
AJR Am J Roentgenol; 1983 Sep; 141(3):469-72. PubMed ID: 6224402
[TBL] [Abstract][Full Text] [Related]
59. [Use of 131I-meta-iodobenzylguanidine in pediatric oncology].
Treuner J
Nuklearmedizin; 1985 Feb; 24(1):26-8. PubMed ID: 4000978
[TBL] [Abstract][Full Text] [Related]
60. [Using 131I-MIBG and 99mTc-MDP bone scan for localization of rare extra-adrenal pheochromocytomas: report of 2 cases].
Kao PF; Huang MJ; You DL; Tzen KY
J Formos Med Assoc; 1992 Dec; 91 Suppl 4():S283-7. PubMed ID: 1363525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
